Zahn Dental Announces Presence at LMT Lab Day East with Strong Focus on 3D Printing, Prosthodontic Components, and Digital Denture Solutions
Dental Laboratory Business of Henry Schein Committed to Delivering Customizable Solutions for All Digital Workflows
Melville, NY September 30, 2022 – Zahn Dental, the laboratory business of Henry Schein, Inc. (Nasdaq: HSIC) today announced its presence at LMT LAB DAY East, offering product demonstrations at its booth, #G2. The largest dental laboratory event in the Northeast, according to LMT, will take place in Tarrytown, NY on October 1 where visitors of Zahn’s booth will learn about Henry Schein’s expanded portfolio of solutions that can help enhance a variety of laboratories’ digital workflows.
Attendees of LMT LAB DAY East can explore the business’ offerings and speak with representatives about the following solutions: Myerson’s Trusana Premium 3D Print Resins, Asiga’s 3D Printers, Desktop Health’s Einstein 3D Printer and Flexcera Print Resins, Keystone Industries’ KeyPrint Resins, DESS’ Prosthetic Components, Zirlux Transitions Zirconia, and Aon’s Zirconia 3D Printer.
“We are eager to reconnect with our customers and industry peers at LAB DAY East, and discuss an array of integrated solutions and breakthrough technologies that can help optimize digital workflows,” said Rita Acquafredda, President, Global Dental Lab & Prosthetic Solutions, Henry Schein. “As a total solutions provider, Zahn is committed to being the partner the dental community can continue to rely on for high-quality merchandise, equipment, technology, and support.”
In addition to its booth presence at LMT LAB DAY East, Zahn announces its upcoming educational roadshow, “Printing Uncovered: Implementing and Mastering a 3D Printing Workflow” where laboratory technicians and owners can learn how to implement new 3D printing equipment and materials into their digital workflow. Visitors of the booth will have an opportunity to register for these upcoming events, and all those not attending can do so here.
To learn more about Zahn Dental’s business and commitment to customers, please visit www.zahndental.com. In November, a new catalog will be available on this site.
About Zahn Dental
Zahn Dental, the dental laboratory business of Henry Schein, is a leading distributor of CAD/CAM equipment, digital materials, removable prosthetic teeth, and traditional core supplies to dental laboratories in North America. The business offers a comprehensive, industry-leading selection of innovative products, breakthrough technologies, value-added services, and technical support that make Zahn a total solution provider.
Laboratories can rely on Zahn's highly trained and knowledgeable specialists, consultants, support technicians, and Team Schein Members to deliver everything a laboratory needs to thrive and succeed. For more information, visit www.zahndental.com.
About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 22,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.
A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 32 countries and territories. The Company's sales reached $12.4 billion in 2021, and have grown at a compound annual rate of approximately 12.5 percent since Henry Schein became a public company in 1995.